Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The EMIF-AD Multimodal Biomarker Discovery study: Design, methods and cohort characteristics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Intellectual Curiosity and Action Initiation are Subtypes of Apathy Affected in Huntington Disease Gene Expansion Carriers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. CCG•CGG interruptions in high-penetrance SCA8 families increase RAN translation and protein toxicity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Endophenotypical drift in Huntington's disease: a 5-year follow-up study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anna Ochalek
  • Balázs Mihalik
  • Hasan X Avci
  • Abinaya Chandrasekaran
  • Annamária Téglási
  • István Bock
  • Maria Lo Giudice
  • Zsuzsanna Táncos
  • Kinga Molnár
  • Lajos László
  • Jørgen E Nielsen
  • Bjørn Holst
  • Kristine Freude
  • Poul Hyttel
  • Julianna Kobolák
  • András Dinnyés
Vis graf over relationer

BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, affecting one in eight adults over 65 years of age. The majority of AD cases are sporadic, with unknown etiology, and only 5% of all patients with AD present the familial monogenic form of the disease. In the present study, our aim was to establish an in vitro cell model based on patient-specific human neurons to study the pathomechanism of sporadic AD.

METHODS: We compared neurons derived from induced pluripotent stem cell (iPSC) lines of patients with early-onset familial Alzheimer's disease (fAD), all caused by mutations in the PSEN1 gene; patients with late-onset sporadic Alzheimer's disease (sAD); and three control individuals without dementia. The iPSC lines were differentiated toward mature cortical neurons, and AD pathological hallmarks were analyzed by RT-qPCR, enzyme-linked immunosorbent assay, and Western blotting methods.

RESULTS: Neurons from patients with fAD and patients with sAD showed increased phosphorylation of TAU protein at all investigated phosphorylation sites. Relative to the control neurons, neurons derived from patients with fAD and patients with sAD exhibited higher levels of extracellular amyloid-β 1-40 (Aβ1-40) and amyloid-β 1-42 (Aβ1-42). However, significantly increased Aβ1-42/Aβ1-40 ratios, which is one of the pathological markers of fAD, were observed only in samples of patients with fAD. Additionally, we detected increased levels of active glycogen synthase kinase 3 β, a physiological kinase of TAU, in neurons derived from AD iPSCs, as well as significant upregulation of amyloid precursor protein (APP) synthesis and APP carboxy-terminal fragment cleavage. Moreover, elevated sensitivity to oxidative stress, as induced by amyloid oligomers or peroxide, was detected in both fAD- and sAD-derived neurons.

CONCLUSIONS: On the basis of the experiments we performed, we can conclude there is no evident difference except secreted Aβ1-40 levels in phenotype between fAD and sAD samples. To our knowledge, this is the first study in which the hyperphosphorylation of TAU protein has been compared in fAD and sAD iPSC-derived neurons. Our findings demonstrate that iPSC technology is suitable to model both fAD and sAD and may provide a platform for developing new treatment strategies for these conditions.

OriginalsprogEngelsk
TidsskriftAlzheimer's research & therapy
Vol/bind9
Udgave nummer1
Sider (fra-til)90
ISSN1758-9193
DOI
StatusUdgivet - 1 dec. 2017

ID: 52178331